Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2011-09-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vegan Diet
Vegan Diet
Vegan diet, which is devoid of animal products and minimal in fat
Supplement
dietary supplement omega3 fatty acids aand vitamins
mixture of omega3 fatty acids aand vitamins
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vegan Diet
Vegan diet, which is devoid of animal products and minimal in fat
dietary supplement omega3 fatty acids aand vitamins
mixture of omega3 fatty acids aand vitamins
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
A diagnosis of rheumatoid arthritis is based on 2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria. Classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10): 24
Joint involvement, designating the metacarpophalangeal joints, proximal interphalangeal joints, the interphalangeal joint of the thumb, second through third metatarsophalangeal joint and wrist as small joints, and elbows, hip joints and knees as large joints:
* Involvement of 1 large joint gives 0 points
* Involvement of 2-10 large joints gives 1 point
* Involvement of 1-3 small joints (with or without involvement of large joints) gives 2 points
* Involvement of4-10 small joints (with or without involvement of large joints) gives 3 points
* Involvement of more than 10 joints (with involvement of at least 1 small joint) gives 5 points
Serological parameters - including the rheumatoid factor as well as anti-citrullinated protein antibody (ACPA):
* Negative RF and negative ACPA gives 0 points
* Low-positive RF or low-positive ACPA gives 2 points
* High-positive RF or high-positive ACPA gives 3 points Acute phase reactants: 1 point for elevated erythrocyte sedimentation rate (ESR) or elevated C-reactive protein (CRP) value Duration of arthritis: 1 point for symptoms lasting six weeks or longer
2. Continuing or recurring pain (i.e., joint pain daily, unless on pain medication).
3. Age at least 18 years
4. Ability and willingness to participate in all components of the study
5. Willingness to be assigned to either the diet group or supplement group
6. Pain medications unchanged within last 6 weeks.
Exclusion Criteria
2. Rheumatoid arthritis for more than 6 years
3. Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
4. Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
5. Pregnancy
6. Unstable medical or psychiatric illness
7. Likely to be disruptive in group sessions (as determined by research staff)
8. Already following a low-fat, vegan diet
9. Lack of English fluency
10. Inability to maintain current medication regimen
11. Inability or unwillingness to participate in all components of the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Physicians Committee for Responsible Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neal Barnard, MD
Role: PRINCIPAL_INVESTIGATOR
Physicians Committee for Responsible Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Physicians Committee for Responsible Medicine
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barnard ND, Levin S, Crosby L, Flores R, Holubkov R, Kahleova H. A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. Am J Lifestyle Med. 2022 Apr 3;19(2):266-275. doi: 10.1177/15598276221081819. eCollection 2025 Feb.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WCCR-ARTH1
Identifier Type: -
Identifier Source: org_study_id